Clinical Trials Browser

alkaloid GB18 × Clear all

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

Phase 1 Not yet recruiting

Cachexia, Neoplasms

NCT07237464 2025-11-19

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants

Phase 1 Recruiting

Cancer Cachexia (CC)